Not approved (research only)Short bioregulator peptidePancreas research
Pancragen
Pancragen is a short synthetic peptide from the bioregulator research tradition studied in a few animal and cell experiments.
What is Pancragen?
Pancragen is a short synthetic peptide from the bioregulator research tradition studied in a few animal and cell experiments. Pancragen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- Pancragen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 7 papers on Pancragen (0 tagged as clinical trials) as of October 19, 2026.
- 7 vendors in our directory listed Pancragen in their public catalog on October 19, 2026.
Regulatory & access status
Pancragen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Pancragen?
PubMed indexes 7 papers mentioning Pancragen in the title or abstract, 0 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Effects of pancragen on the differentiation of pancreatic cells during their ageing. — Bull Exp Biol Med, 2013
- [Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys]. — Adv Gerontol, 2015
- Prospects of using pancragen for correction of metabolic disorders in elderly people. — Bull Exp Biol Med, 2011
- Effect of pancragen on blood glucose level, capillary permeability and adhesion in rats with experimental diabetes mellitus. — Bull Exp Biol Med, 2007
- [Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys]. — Adv Gerontol, 2014
- Peptides tissue-specifically stimulate cell differentiation during their aging. — Bull Exp Biol Med, 2012
What the evidence does not show
- Paper counts measure research attention, not whether Pancragen works or is safe.
- No clinical trial in humans is tagged in PubMed under this name.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list Pancragen
7 vendors in our directory listed a product matching Pancragen in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- BioLongevity Labs
- Core Peptides
- Eros Peptides
- Liberty Peptides
- Pure Lab Peptides
- Swiss Chems
- Xcel Peptides
Prices per mg, where we could verify them, are on our price comparison.
Pancragen reconstitution math
Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.
Pancragen FAQ
Is Pancragen FDA-approved?
Pancragen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is Pancragen safe?
There are no published human safety trials of Pancragen that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.
How much research is there on Pancragen?
PubMed indexes 7 papers on Pancragen (0 tagged as clinical trials) as of October 19, 2026.
Who sells Pancragen?
BioLongevity Labs, Core Peptides, Eros Peptides, Liberty Peptides, Pure Lab Peptides, Swiss Chems and 1 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
TRHMelanotan IPNC-27OvagenAOD-9604 + CJC-1295 + ipamorelin blendCardiogenLivagenCortagenAll bioregulators & other research compounds